Healthline lands Drugs.com ad sales deal

Share this article:
Healthline lands Drugs.com ad sales deal
Healthline lands Drugs.com ad sales deal
Healthline Networks has secured a deal with Drugs.com giving it exclusive rights to sell consumer ads on the site, which boasts 8.8 million unique visitors per month.

The agreement boosts Healthline's reach to nearly 55 million monthly uniques, said the San Francisco firm, or about half the monthly health information audience, per comScore stats.

“We wanted a partner that could help marketers take advantage of our critical position in the treatment consideration process,” said Drugs.com CEO Philip Thornton. “Healthline not only gives us a roster of strategic sellers with deep DTC experience but original, engaging content and visual learning solutions that can help marketers reach consumers and healthcare providers at a critical point of decision.”

Healthline, whose backers include Kaiser Permanente, Reed Elsevier, GE/NBC Peacock Fund and Aetna, offers search, advertising and content services through partnerships with 50-plus destination sites including web publishers, portals, search engines, employers and health plans.
Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.